Electronic Drug Delivery Systems Market Trends Reshaping Industry Growth Through 2030
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Electronic Drug Delivery Systems Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The electronic drug delivery systems market has experienced substantial growth in recent years. It is forecast to rise from $11.93 billion in 2025 to $13.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The past growth in this sector can be attributed to the increasing incidence of chronic diseases, the broadening scope of injectable and inhalable therapies, the expanding use of infusion-based treatments, a surge in home healthcare adoption, and the availability of electronic drug delivery platforms.
The electronic drug delivery systems market size is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $19.44 billion, exhibiting a compound annual growth rate (CAGR) of 10.4%. Several factors are expected to fuel this growth during the forecast period, including the escalating demand for tailored drug delivery, the increasing embrace of digital health ecosystems, the expansion of remote patient monitoring capabilities, a heightened emphasis on outcomes driven by adherence, and the greater incorporation of AI-based dosing algorithms. Key trends during this period are projected to encompass the wider adoption of intelligent drug delivery devices, the growing integration of interconnected and wearable delivery systems, an increased utilization of precision dose control technologies, the broadening availability of patient-centric self-administration devices, and an intensified focus on tracking therapy adherence.
Get A Free Sample Report With In-Depth Market Insights:
Electronic Drug Delivery Systems Market Demand Drivers Opening New Revenue Streams
The increasing incidence of chronic illnesses is anticipated to propel the growth of the electronic drug delivery systems market in the future. A chronic disease is defined as an ailment or condition persisting for over a year and necessitating continuous medical care. Electronic drug delivery systems are utilized for regulating drug doses and simplifying the monitoring of medication for individuals suffering from chronic conditions. As an illustration, in January 2023, the National Library of Medicine, a US-based agency, reported that the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050. Consequently, the rising prevalence of chronic diseases will drive the electronic delivery system market.
Electronic Drug Delivery Systems Market Segment Analysis And Revenue Potential
The electronic drug delivery systems market covered in this report is segmented –
1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules
2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
3) By System Type: Battery-Powered Systems, Rechargeable Systems
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies
5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
Subsegments:
1) By Electronic Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps
2) By Electronic Injection Pens: Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens
3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors
4) By Electronic Inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers
5) By Electronic Capsules: Smart Capsules, Digital Capsules With Sensors
Electronic Drug Delivery Systems Market Trends Powering Strategic Industry Growth
Leading firms within the electronic drug delivery systems market are prioritizing novel approaches, including reusable electronic injector platforms, aimed at improving the accuracy of drug administration, patient compliance, and environmental responsibility. Such a platform represents a battery-operated, intelligent injection tool capable of repeated use to administer exact medication dosages, simultaneously monitoring use and encouraging patient conformity. As an illustration, Portal Instruments Inc., a US-based medical device firm, unveiled PRIME Nexus in January 2025. This novel reusable electronic injector platform was created to optimize the delivery of injectable medicines, offering particular improvements in drug delivery precision, adaptability, and long-term viability. The system accommodates various drug container dimensions, such as 1 mL and 2.25 mL pre-filled syringes and 3 mL cartridges, and is capable of managing highly viscous preparations up to 600 cP. This device provides customizable injection management and optional connection features for tracking adherence and sharing information with healthcare professionals. Its capability for reuse contributes to sustainability by decreasing medical refuse and diminishing overall expenditures associated with injections.
Electronic Drug Delivery Systems Market Key Participants And Competitive Landscape
Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.
View The Full Electronic Drug Delivery Systems Market Report:
Electronic Drug Delivery Systems Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
